Doctor welcomes reduced age limit for asthma drug

A leading respiratory physician has welcomed the new PBS listing for omalizumab (Xolair) which will give children from six years access to the drug for severe allergic asthma. The therapy was...

Spotlight

Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More